Jiangli Yan
Senior Director, Analytical Science & Technology, Vertex Pharmaceuticals
Seminars
Wednesday 2nd December 2026
Building a Control Strategy for Complex Analytical Methods to Ensure Commercial Testing Stability for Cell Therapies
12:00 pm
- Evaluating when early characterization assays should be retained, removed or moved into release testing
- Refining specifications and acceptance criteria as development progresses across phases
- Aligning analytical decisions with evolving CMC and regulatory strategy on the path to BLA
